MKMarta Krzyżanowska

Marta Krzyżanowska

*This is an algorithmically generated author record based on publicly available information.

Marta Krzyżanowska has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Growing a Better Airway: Rapid Maxillary Expansion, Nasal Breathing, and the Open Question of Aerobic Development in the Child and Adolescent Athlete

    by Karolina Kot-Ceglarek, Izabela Truchel, Julia Szymańska, Natalia Smyczyńska, Mikołaj Kubik, Marta Krzyżanowska, Julia Kamut

    Background. Rapid maxillary expansion (RME) involves the widening of the maxilla and midpalatal suture. Transverse maxillary deficiency has been identified as a factor that can increase nasal airway resistance and contribute to sleep-disordered breathing (SDB) in children. However, there has been no investigation into whether fixing this issue can enhance aerobic development in young athletes. Objective. This study aims to combine the existing research on RME and airway issues with pediatric exercise physiology to create testable hypotheses regarding nasal breathing efficiency, recovery and aerobic training capacity in young athletes. Methods. A thorough structured narrative review was conducted, utilizing a systematic approach to evaluate literature from PubMed, Scopus, Web of Science, and Embase. The AMSTAR-2 and GRADE frameworks were applied to assess secondary syntheses. Results. RME consistently decreases nasal airway resistance (with moderate certainty in the short to medium term). The impact on pediatric obstructive sleep apnea (OSA) is towards improvement but remains of low to moderate significance — RME does not significantly affect the apnoea–hypopnoea index by itself, with enhancements mainly found in oxygenation and in combination treatments. This positions RME as a secondary or adjunct option. Connections to exercise efficiency and performance are weak, indirect, and somewhat null; there are currently no trials linking RME to aerobic outcomes in athletes. Conclusion. While RME could facilitate nasal breathing and support better recovery through improved sleep, there is no substantiated evidence indicating a direct improvement in athletic performance; this highlights the need for further research within pediatric exercise physiology.

  • Open Access

    The Sunshine-Vitamin Deficit in the Athlete's Mouth: Vitamin D Levels May Influence the Effectiveness of Orthodontic Tooth Movement, Risk of Root Resorption and Retention

    by Natalia Smyczyńska, Mikołaj Kubik, Marta Krzyżanowska, Izabela Truchel, Julia Szymańska, Aleksandra Barszcz, Karolina Kot-Ceglarek

    Approximately 56% of athletes suffer from low vitamin D levels due to a combination of reasons, including indoor training, high latitude, lack of UV-B radiation in winter, and energy deficit in sports. Furthermore, active 1,25-dihydroxyvitamin D directly modulates the RANKL/OPG system that is required for alveolar remodeling in OTM [6,8,9]. The purpose of this work is the combination of the information about vitamin D deficiency in athletes with existing data from human and preclinical studies concerning the influence of vitamin D on OTM and investigation of whether the levels of 25(OH)D in serum are the common factor affecting orthodontic outcomes in active people. For the analysis of data, a systematic narrative review using the databases PubMed, Scopus, Web of Science, Embase and Cochrane has been carried out. According to small RCTs on human subjects, vitamin D may promote OTM (SMD≈1.43, very low certainty, large CI; [1]) although there is no data for EARR. Studies on animals support the hypothesis of tension side consolidation [15]. While vitamin D deficiency in athletes is highly prevalent but treatable, there is currently a complete absence of direct clinical data-zero published studies worldwide-evaluating OTM, EARR, or retention specifically within vitamin D-deficient athletic cohorts, leaving the clinical impact of secondary hyperparathyroidism entirely unquantified. Serum 25(OH)D is a relatively simple and inexpensive variable which unites sports nutrition and orthodontics. There should be more targeted research on specific groups of athletes to prove the hypothesis about possible deficiency as a variable.

  • Open Access

    From Overjet to Overhead: Malocclusion and Increased Overjet as a Potential Upstream Risk Multiplier for Sports-Related Dentofacial Trauma

    by Julia Szymańska, Marta Krzyżanowska, Julia Kamut, Izabela Truchel, Zuzanna Pająk, Karolina Kot-Ceglarek, Natalia Smyczyńska, Mikołaj Kubik, Julia Jaguszewska, Weronika Górska

    Background: A greater overjet combined with poor lip control has long been recognized as a significant morphological indicator of anterior traumatic dental injury (TDI), with sports being a primary environment for such injuries. Typically, the risks associated with orthodontics and the prevalence of TDI among athletes are examined separately. Objective: This review aims to evaluate how far orthodontic morphology influences the chain of athlete-related TDI burdens and whether preventative measures can lessen these effects. Methods: A carefully structured narrative review with a systematic appraisal approach was conducted using databases such as PubMed, Scopus, Web of Science, SPORTDiscus, and Cochrane. The analysis utilized RoB 2, Newcastle-Ottawa, and AMSTAR-2 frameworks, along with GRADE for the sourced evidence. Results: An overjet measurement exceeding 3-3.5 mm approximately doubles the risk of incisor trauma, while inadequate lip coverage increases that risk by about 2.6 times. TDI adversely affects oral health-related quality of life (OHRQoL), self-esteem, and social confidence, with lifetime restorative treatment incurring various direct and indirect costs. Conclusions: The use of mouthguards can lower the incidence of orofacial injuries, and early correction of Class II malocclusion can reduce incisal trauma, with relatively low to moderate certainty. Orthodontic morphology represents a potentially alterable upstream factor that amplifies a significant biopsychosocial burden in athletes.

  • Open Access

    ROLE OF PRO- AND ANTI-INFLAMMATORY INTERLEUKINS IN PERIODONTITIS: MOLECULAR, IMMUNOLOGICAL, AND THERAPEUTIC SIGNIFICANCE

    by Natasza Jankowska, Marta Krzyżanowska, Agata WnęK, Zuzanna Hucała, Natalia Dymel, Weronika Jagiełło, Natalia Le-Hong, Alicja Biskup

    Periodontitis is a chronic, biofilm-associated inflammatory disease in which tissue destruction reflects an altered host immune response more than the direct action of bacteria alone. This structured narrative review examines the molecular, immunological, diagnostic, and therapeutic significance of pro- and anti-inflammatory interleukins in periodontitis. A targeted literature search was performed in PubMed/MEDLINE, PubMed Central, Scopus, Web of Science, and Google Scholar for English-language publications from 2016 to 2026. Search terms combined 'periodontitis,' 'periodontal disease,' 'interleukin,' 'cytokine,' 'IL-1β,' 'IL-6,' 'IL-10,' 'IL-17,' 'IL-23,' 'IL-33,' 'IL-35,' 'IL-38,' 'inflammasome,' 'saliva,' and 'gingival crevicular fluid.' In the expanded search, 106 records were screened by title and abstract, 53 full-text papers were assessed, and 35 peer-reviewed publications were selected because they directly addressed interleukin expression, signaling, biomarker value, genetic variation, or therapeutic modulation in periodontal disease. Overall, IL-1β and IL-6 remain the most consistent salivary and gingival crevicular fluid biomarkers of disease severity. The IL-23/IL-17 pathway links adaptive immunity with neutrophil recruitment, RANKL expression, and osteoclastogenesis, whereas IL-10, IL-35, and IL-38 illustrate the importance of regulatory cytokine networks. Interleukin-directed therapy is not yet ready for routine periodontal use, but local, phenotype-guided immunomodulation may become a rational adjunct to conventional periodontal treatment.

  • Open Access

    Impact of air pollution on otolaryngological disease

    by Zuzanna Parfienowicz, Anna Drużdżel, Marta Krzyżanowska, Kacper Curzytek

    Introduction and objective: Air pollution is a major environmental health problem associated with increased respiratory morbidity and mortality. Pollutants such as particulate matter (PM2,5, PM10), nitrogen dioxide, sulpher dioxide, ozone, and carbon monoxide may damage the...

  • Open Access

    THE SOCIO-CLINICAL IMPACT OF GLP-1 RECEPTOR AGONISTS ON ORAL HEALTH: BRIDGING THE BIOPSYCHOSOCIAL GAP THROUGH DIGITAL HEALTH TECHNOLOGIES

    by Marta Krzyżanowska, Natalia Smyczyńska, Natasza Jankowska, Sebastian Trochim, Mikołaj Kubik, Kacper Curzytek

    The exponential global adoption of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for metabolic management has inadvertently unmasked a secondary crisis within the oral-systemic axis. This systematic review aims to synthesize the clinical pathophysiology of GLP-1 RA-induced oral dysfunction and evaluate its broader biopsychosocial and economic impacts, proposing digital health interventions as a mitigating framework. Utilizing a multi-stage search strategy across PubMed/MEDLINE, Scopus, Web of Science, and the Cochrane Library (up to 2025), 34 out of 142 screened sources were selected for high-level synthesis. Findings indicate that GLP-1 RAs disrupt salivary homeostasis by down-regulating aquaporin-5 and inducing secondary gastroesophageal reflux, precipitating rapid perimylolysis, xerostomia, and dysgeusia. Beyond physiological damage, this localized deterioration acts as a severe psychosocial stressor, driving social isolation, elevated anxiety, and occupational presenteeism, fundamentally altering the depreciation rate of the patient’s "Health Capital". The current siloed architecture of medical and dental care fails to address this multifaceted burden. The review concludes that a paradigm shift toward Value-Based Healthcare is imperative. By embedding digital health interventions—such as continuous Internet of Things (IoT) salivary biomonitoring, Artificial Intelligence (AI) diagnostic screening, and teledentistry—into a mandatory "Diabeto-Dental Care Pathway," reactive interventions can be replaced with proactive prevention. Bridging the medical-dental divide through technology and enhanced eHealth literacy is essential to safeguard the socio-economic vitality of patients undergoing incretin therapies.

  • Open Access

    The Role of Vitamin D in Inflammatory Bowel Disease: Clinical Relevance and Therapeutic Potential

    by Anna Drużdżel, Natalia Pawelec, Weronika Mazur, Marta Krzyżanowska, Kacper Curzytek, Zuzanna Parfienowicz

    Background:Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is characterized by chronic relapsing inflammation of the gastrointestinal tract. Increasing evidence suggests that vitamin D plays an important role in immune regulation and intestinal barrier integrity. Aim:The aim of this review was to evaluate the clinical relevance of serum vitamin D levels in patients with inflammatory bowel disease and to assess the potential role of vitamin D supplementation. Material and methods: A narrative review of current literature concerning vitamin D and IBD was conducted using clinical studies, systematic reviews, meta-analyses, and experimental studies retrieved from databases including PubMed and Scopus. Results: Vitamin D deficiency is highly prevalent among patients with IBD and has been associated with increased disease activity, higher inflammatory burden, greater risk of relapse and poorer quality of life. Low serum 25(OH)D levels correlate with inflammatory markers such as C-reactive protein and fecal calprotectin. Experimental and clinical studies suggest that vitamin D influences intestinal inflammation through modulation of immune responses, maintenance of epithelial barrier function, and regulation of gut microbiota. Available evidence indicates that vitamin D supplementation may improve selected clinical outcomes, particularly in patients with Crohn’s disease in remission, although current data remain heterogeneous. Conclusions:Vitamin D appears to be a clinically relevant and modifiable factor in IBD management. Routine assessment and correction of vitamin D deficiency may represent a useful adjunct to standard therapy; however, further randomized controlled trials are required to establish optimal supplementation strategies.

  • Open Access

    Exercise Therapy in Type 2 Diabetes Mellitus with Special Emphasis on Running: Effects on Glycemic Control, Metabolic Adaptations, and Psychosocial Outcomes – A Narrative Review

    by Maciej Szczupaj, Jakub Rudnicki, Marta Krzyżanowska, Wiktoria Leja, Maciej Błaszczak, Katarzyna Latalska, Andżelika Pastuszak, Konrad Borkowski, Julia Zjawiony, Zeeshan Zulfiqar

    Type 2 diabetes mellitus is a chronic metabolic disease that affects over 500 million adults all over the world and represents one of the most important public health challenges of the 21th century. Regular physical activity and structured exercise therapy in particular, is a cornerstone of evidence-based T2DM management. This narrative review synthesizes current evidence on the effects of exercise training on glycemic control and related metabolic, physiological, and psychosocial outcomes in individuals with T2DM, with special emphasis on running as a clinically relevant and globally accessible form of aerobic exercise. A structured literature search was conducted in PubMed, Scopus, and Google Scholar, encompassing publications from the last decade, with particular emphasis on studies published between 2020 and 2026. Evidence from meta-analyses and randomized controlled trials consistently demonstrates that structured aerobic exercise produces significant reductions in glycated haemoglobin (HbA1c) and fasting blood glucose. Additionally, prospective cohort study data found running to significantly reduce the risk of developing T2DM by 28%. Studies have also reported a dose response relationship when examining performed run by duration, frequency, distance, and speed. Molecular mechanisms responsible for the glycemic improvements due to exercise include AMPK mediated GLUT4 translocation into skeletal muscle cells, changes in post translational modification to insulin signaling proteins, and increased mitochondrial biogenesis. In addition to improving glycemia, regular exercise has been shown to decrease both visceral and hepatic ectopic fat, improve multiple cardiometabolic risk factors, and produce psychologically relevant advantages including reduced symptoms of depression and anxiety. Therefore, exercise therapy, using running as one of its most accessible and effective forms, provides advantageous approach to managing all aspects of T2DM.

  • Open Access

    The oral exposome – integrating environmental determinants into the etiology of oral pathologies

    by Marta Krzyżanowska, Anna Drużdżel, Zuzanna Parfienowicz, Kacper Curzytek, Maciej Szczupaj

    Introduction: Oral diseases remain a major global health challenge, affecting app. 3.5 billion people. While traditional etiological models have focused primarily on behavioural and microbial factors, the disproportionate disease burden in industrializing regions suggests the presence of...


  • Open Access

    CLINICAL PRESENTATION OF LEFT VENTRICULAR NONCOMPACTION DIAGNOSED IN ADULTS

    by Kacper Curzytek, Marcelina Podleśna, Karol Chromiak, Aleksandra StęPień, Kacper Bączek, Kacper Bluczak, Marta Krzyżanowska, Anna Drużdżel, Zuzanna Parfienowicz, Katarzyna Czechowicz

    Left ventricular noncompaction (LVNC) is a rare, morphologically and genetically heterogeneous form of cardiomyopathy, the pathogenesis, classification, and clinical significance of which remain subjects of ongoing debate. The aim of this review is to present the current state of knowledge regarding the classification, pathophysiology, diagnostics, genetic determinants, clinical presentation, and therapeutic management of LVNC. The European Society of Cardiology (ESC) classifies LVNC as an unclassified cardiomyopathy, whereas the American Heart Association (AHA) considers it a genetically determined cardiac disorder. The characteristic morphology arises from abnormal compaction of the left ventricular trabeculae during embryogenesis, although an acquired or adaptive origin of these changes is also possible. Diagnostic evaluation relies primarily on echocardiography and cardiac magnetic resonance imaging; however, the lack of uniform morphological criteria contributes to both overdiagnosis and underdiagnosis. From a genetic perspective, sarcomeric gene mutations predominate and are associated with more severe clinical outcomes. Clinical manifestations include heart failure, arrhythmias, and thromboembolic complications, with reduced left ventricular ejection fraction being the principal prognostic factor. Therapeutic management follows general heart failure treatment strategies, thromboembolism prevention, and implantation of cardiac devices; in advanced cases, heart transplantation or mechanical circulatory support may be considered. An integrated diagnostic approach and the MOGE(S) classification system may serve as a foundation for future standardization.